Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
A recent study found that combining SAMe with antidepressant medication improved symptoms in 50% of participants and led to complete remission in 43% after six weeks. The study, led by Massachusetts General Hospital, investigated the efficacy of SAMe in patients with continuing symptoms despite initial treatment.
A two-year depression treatment program improved employee productivity by an average of 6% and reduced absenteeism by 22%. Consistently employed patients benefited the most from enhanced treatment, making significant gains in productivity while reducing symptoms of depression.
Social support significantly reduces the risk of depression in children who have experienced maltreatment, according to a new study published by Yale University. The research found that positive relationships with caregivers or peers can mitigate the negative effects of childhood trauma on mental health.
A University of Toronto study identifies immigration, lack of partner support, and readiness for hospital discharge as factors increasing new mothers' risk of developing depressive symptoms. Early detection can lead to early intervention and improved maternal and child outcomes.
Researchers at Northwestern Memorial Hospital are testing a new Transcranial Magnetic Stimulation (TMS) treatment for major depression. The study aims to prove the effectiveness of TMS as a treatment alternative and compare its effects with placebo, with the goal of securing FDA clearance for clinical use.
A multi-university study found that levels of fibroblast growth factors (FGFs) and their receptors were significantly lower in people with severe clinical depression. The researchers also found that those who had been taking antidepressants before death had levels closer to normal.
A study of supportive-expressive group therapy for women with BRCA1 or 2 gene mutations found improvements in anxiety, depression, and decision-making. The therapy helped women weigh treatment choices by exploring feelings and perspectives.
Parkinson's disease is often associated with depression, a condition that can significantly impact patients' lives. Research suggests that depression is part of the illness and not just a reaction to the disease.
A new study found Seroquel to be effective in rapidly relieving core symptoms of depression, such as sadness and suicidal thoughts, in patients with rapid-cycling bipolar disorder. The treatment was also well-tolerated, with a low risk of mania compared to other treatments.
A recent clinical trial demonstrated the effectiveness of duloxetine in reducing pain and improving disease symptoms in female fibromyalgia patients. The study showed significant improvements in tender point measures and pressure pain threshold, with benefits also observed in emotional and physical functioning.
A study found that depressed patients experience less improvement in physical symptoms than emotional symptoms during antidepressant therapy. Physical symptoms often plateau after the initial month of treatment, emphasizing the importance of considering additional therapies.
A randomized trial found that telephone-based psychotherapy added significantly to usual care pharmacotherapy for patients with depression. The study showed improved patient-rated improvement and satisfaction rates compared to usual care.
A four-year study of 1,222 caregiver-patient pairs found that caregivers who institutionalized their loved ones experienced similar symptoms of depression and anxiety as those who cared for them at home. Cognitive and functional declines in patients are common, leading to feelings of guilt and self-blame among caregivers.
A study by Dr. Kurt Kroenke found that depression is a risk factor for pain symptoms, with muscle pain and headaches being two or three times more common in people with depression. Physical symptoms may not respond to antidepressant treatment as well as emotional symptoms, and can linger longer.
University of Alberta researchers provide independent verification that CFS patients are distinct from those with depression. The study used electrodermal activity to demonstrate differences in skin temperatures and electrodermal activity between CFS and depression patients.
The TADS clinical trial found combined antidepressant and talk therapy treatment yielded the best results, followed by antidepressants alone. Talk therapy on its own was no more effective than placebo.
The TADS study found that treatment combining fluoxetine with CBT was superior to each alone in improving rates of response for adolescents with MDD. Clinically significant suicidal thinking improved significantly in all four treatment groups, with the greatest reduction seen in those receiving fluoxetine and CBT.
A stage one trial found that fluoxetine plus CBT offered greater effectiveness in treatment than the drug alone for adolescents diagnosed with MDD. Combination therapy proved superior to fluoxetine and CBT alone, with a 71 percent response rate.
A study by UT Southwestern Medical Center found that teens with depression experience significant improvement when treated with a combination of medication and cognitive-behavior therapy. The treatment resulted in a 71% improvement rate, compared to 60% for those taking Prozac alone or 43% for those receiving only therapy.
Research suggests that depression significantly impacts life satisfaction, while anxiety has a minimal effect. A disposition to be cheerful is more important for happiness than external factors like success or popularity.
Researchers found that women experiencing depressive symptoms, binge drinking, or smoking during pregnancy may be at risk for depression and alcohol use during the first postpartum year. Early identification and treatment of these comorbid conditions can benefit both mothers and children.
A brain imaging study found that people prone to depression have an overactive emotion-regulating brain circuit, even when they're not depressed. When tryptophan was depleted, most subjects with a history of mood disorder experienced temporary symptoms.
Researchers identify molecular pathway in brain that explains why patients with inflammatory diseases develop depression. By understanding this mechanism, scientists hope to help patients avoid depression while benefiting from immune-boosting treatments.
A study of 200 adults found that physicians often misattribute physical symptoms to causes other than depression. Patients with physical symptoms were less likely to accept antidepressants and showed improved outcomes when presented with psychological symptoms.
Researchers Wade Berrettini and Irwin Lucki received Distinguished Investigator Awards to study gene identification and behavioral effects of neurotrophins. Monica Gonzalez won a Young Investigator Award to investigate the effect of long-term light deprivation on depression.
Research using proton magnetic resonance spectroscopy found reduced cortical GABA levels and increased glutamate in melancholic depression patients, a subset of major depressive disorder. The study adds to evidence suggesting both GABA and glutamate systems contribute to mood disorders' pathophysiology.
Researchers found a 31% greater number of nerve cells in the thalamus involved with emotional regulation, leading to physical enlargement and structural abnormalities in individuals with severe depression. The study suggests that brain development abnormalities are responsible for depression.
Three Yale researchers have been awarded grants from the Donaghue Women's Health Investigator Program to explore postpartum depression and hereditary hemorrhagic telangiectasia. These studies aim to improve treatment strategies and outcomes for women, with a focus on sex differences in health and disease.
Women with PTSD experience more medical conditions and poorer physical health compared to those with depression or no history of mental health issues. The study found that PTSD affects 17% of women under 45, while depression rates are higher in older age groups.
A national health survey found that depression in young women is associated with an increased risk of developing the metabolic syndrome, a cluster of factors linked to heart disease. The study also suggests that depression can cause physiological changes that increase the risk of heart disease.
The BOLDER trial found SEROQUEL significantly reduces anxiety symptoms in bipolar depression patients within the first week of treatment. It also improves depressive symptoms and is well-tolerated with a favorable side effect profile.
A new study will evaluate the effectiveness of a face-to-face support group for older adults with depression and HIV/AIDS. The intervention aims to improve coping mechanisms, quality of life, and social support.
A study found that childhood conduct problems predict depression, violence, and social phobia in young adults. Early conduct problems were a strong predictor of later violence, with children three and a half times more likely to engage in violent behavior.
The BOLDER study found SEROQUEL to be superior to placebo in reducing depressive symptoms and anxiety in patients with bipolar disorder. Approximately 50% of patients achieved remission from their bipolar depression symptoms.
A randomized trial of 542 patients with bipolar depression found Seroquel (quetiapine fumarate) to be effective in reducing symptoms, with a response rate of 50% compared to placebo. The study suggests that Seroquel may be a viable treatment option for bipolar disorder, particularly for patients who exhibit anxiety and agitation.
A study of 1,248 people with depression found that those who didn't recover from symptoms after routine treatment were more likely to experience persistent depression and report side effects from medication. These individuals often felt they received inadequate care from their doctors, leading to continued use of healthcare services.
A NIH study found that combination therapy of psychotherapy and pharmacotherapy improved treatment adherence and reduced depression in injection drug users. The study showed nearly 40% of participants fully adherent to treatment were in remission, compared to 12% without treatment.
A study published in the American Journal of Psychiatry found that enhanced counseling, including individual and family therapy, reduced symptoms of depression among caregivers of loved ones with Alzheimer's disease. After one year, 29.8% of caregivers in the enhanced group showed significant improvement.
A recent study published in the American Journal of Psychiatry found that moderately depressed seniors require significantly more hours of care than those without symptoms. If caregivers were paid for their work, the annual cost would be approximately $9 billion, highlighting the impact of depression on seniors and their loved ones.
A study of nearly 3,300 subjects found that any level of depressed mood was associated with a 40% higher risk for stroke among the entire cohort. In contrast, among white subjects, greater severity of symptoms more than doubled the risk of stroke.
A study analyzing published and unpublished trials found that most SSRI antidepressants pose a higher risk than benefits in treating childhood depression. The analysis highlights the need for greater access to unpublished data from the pharmaceutical industry to ensure accurate treatment guidelines.
Concussions are linked to depression and confusion in athletes after injury. The study found that emotional changes disappeared within three weeks of recovery.
A randomized controlled trial found that a home-based program, PEARLS, significantly improved depressive symptoms and health-related quality of life in medically ill, low-income, mostly homebound older adults. The study showed promising results for non-pharmacological treatments in this vulnerable population.
Research links severe atherosclerosis to increased prevalence of depressive disorders in older adults. Patients with coronary and aortic calcifications are at higher risk of developing depressive symptoms.
A study by Express Scripts found that antidepressant use increased significantly among children and adolescents between 1998 and 2002. The fastest-growing segment was preschoolers aged 0-5 years, with use doubling in girls and growing by 64% in boys.
Researchers found that depression is often associated with an underlying autoimmune process affecting the thyroid gland. The study used thyroid function indicators to predict patients' responsiveness to antidepressants, achieving an almost 90% success rate.
A twin study found a possible connection between depression and heart disease, with decreased heart rate variability (HRV) being a key factor. The study suggests that treating clinical depression, including minor forms, may help reduce the risk of heart disease by normalizing HRV.
Researchers at Duke University Medical Center found that women with coronary artery disease are twice as likely to die if they exhibit symptoms of depression. The study analyzed the Beck Depression Inventory scores of 265 women admitted for a diagnostic cardiac catheterization and followed them for up to 3.5 years.
A study found that care managers can significantly improve clinical outcomes for patients with depression, reducing suicidal thoughts and improving treatment response rates. The intervention, which involved structured treatment guidelines and regular follow-up, led to faster resolution of suicidal thinking in patients who received it.
Recent studies suggest that selective serotonin reuptake inhibitors (SSRIs) may be effective in treating social anxiety in alcohol-dependent individuals, particularly those with severe depression. Additionally, anticonvulsants like sodium valproate and atypical antipsychotics like clozapine show promise in reducing alcohol use among bi...
Researchers present findings on various stroke treatments, including the effectiveness of IV magnesium in reducing death and improving functional outcome. Additionally, studies show promise for statins, oxygen therapy, and clot-busting therapies in improving neurological outcomes after ischemic stroke.
A recent study found that 25% of teenage girls experience major depression, highlighting the need for earlier identification and treatment. Decreases in social support and increases in smoking were linked to increased depressive symptoms.
A study of 278 men aged 45+ without depression found that low testosterone levels were associated with a higher incidence of diagnosed depression. Men with hypogonadism were 4.2 times more likely to be diagnosed with depression than those with normal testosterone levels.
UT Southwestern researchers are studying the effect of supervised exercise on individuals taking SSRIs, with preliminary results indicating positive responses from patients. The goal is to determine if exercise can augment SSRI treatment and reduce all symptoms of depression.
A new study found that men who have sex with men experience depression at a rate three times higher than the general population. The issues related to homophobia were strongly predictive of depression among MSM, suggesting a direct link between social attitudes and mental health outcomes.
A clinical trial found that depression improved in most patients after three months of drug therapy, but 24% persisted with high scores. Moderate to severe pain at the start of treatment was associated with a higher risk of poor response.
Researchers found that adolescents with early onset depression had significantly smaller left hippocampuses compared to healthy controls. The study also revealed that those with longer histories of depression had larger hippocampuses, suggesting that initial differences may not be apparent in adult patients.
Postnatal depression is a severe mental illness with long-term effects, responding to treatment and requiring multidisciplinary care. The Lancet article shares a personal account and highlights the importance of recognition, support groups, and medical community response.
A study of 18,980 adults found that morning headaches were associated with depression, anxiety disorders, and other conditions, including sleep-related breathing disorders and musculoskeletal diseases.
Researchers found that cognitive behavioral therapy targets limbic and cortical regions in a distinct pattern from drug therapy, which changes chemical balance in the brain. The study suggests that brain scans may one day help doctors determine the most effective treatment for patients with depression.